This work was supported by the National Institutes of Health (GM054111 and GM038047), the Center of Cancer Nanotechnology Excellence (U54A119341), and the CDMRP Breast Cancer Research Program (BC073413 and BC076723). Thanks to Prof. David H. Thompson (Purdue University) for providing folate-PEG3350-DSPE, Rebecca Marvin for help with ICP-MS, Prof. Robert C. MacDonald for critical reading, Sang-Min Lee and Dr. Mala Shanmugam for advice.
Coencapsulation of Arsenic- and Platinum-based Drugs for Targeted Cancer Treatment†
Version of Record online: 5 NOV 2009
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Angewandte Chemie International Edition
Volume 48, Issue 49, pages 9295–9299, November 23, 2009
How to Cite
Chen, H., Pazicni, S., Krett, Nancy L., Ahn, Richard W., Penner-Hahn, James E., Rosen, Steven T. and O'Halloran, Thomas V. (2009), Coencapsulation of Arsenic- and Platinum-based Drugs for Targeted Cancer Treatment. Angew. Chem. Int. Ed., 48: 9295–9299. doi: 10.1002/anie.200903655
- Issue online: 17 NOV 2009
- Version of Record online: 5 NOV 2009
- Manuscript Revised: 14 SEP 2009
- Manuscript Received: 3 JUL 2009
- National Institutes of Health. Grant Numbers: GM054111, GM038047
- Center of Cancer Nanotechnology Excellence
- CDMRP Breast Cancer Research Program. Grant Numbers: BC073413, BC076723
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.